Repligen Financials - Benzinga

Repligen Corp

RGENNASDAQ

Trade with Public

Trade with Public

$163.90

4.462.8%

At close: Aug 6, 5:00 PM EST

$163.90

4.462.8%

Pre-Market: 5:51 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Repligen Financials

Repligen (RGEN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Repligen Q2 Adj. EPS $0.54 Beats $0.45 Estimate, Sales $204.128M Beat $201.483M Estimate

Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.45 by 20 percent. This is a 45.95 percent increase over earnings of $0.37 per share from the same

Benzinga Newsdesk

PRO
Repligen Raises FY2026 Adj EPS Guidance from $1.97-$2.05 to $2.03-$2.09 vs $2.00 Est; Raises FY2026 Sales Guidance from $803.000M-$833.000M to $813.000M-$835.000M vs $822.537M Est

Repligen (NASDAQ:RGEN) raises FY2026 Adj EPS guidance from $1.97-$2.05 to $2.03-$2.09 vs $2.00 analyst estimate. Raises FY2026 sales outlook from $803.000 million-$833.000 million to $813.000 million-$835.000 million vs

Benzinga Newsdesk

PRO
Repligen Raises FY2026 Adj EPS Guidance from $1.93-$2.01 to $1.97-$2.05 vs $1.97 Est; Lowers FY2026 Sales Guidance from $810.000M-$840.000M to $803.000M-$833.000M vs $827.641M Est

CURRENT GUIDANCE (at May 5, 2026) FY 2026Adjusted (non-GAAP)Total Reported Revenue$803M - $833MReported Growth9% - 13%Organic Growth9% - 13%Gross Margin53.7% - 54.2%Income from Operations$124M - $132MOperating

Benzinga Newsdesk

PRO
Repligen Raises FY2026 Adj EPS Guidance from $1.93-$2.01 to $1.97-$2.05 vs $1.97 Est

FINANCIAL GUIDANCE FOR FULL YEAR 2026All adjusted figures are non-GAAPOur financial guidance for the full year 2026 is based on expectations for our existing business. Our Adjusted (non-GAAP) guidance excludes the

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Repligen Q1 Adj. EPS $0.48 Beats $0.39 Estimate, Sales $194.255M Beat $192.279M Estimate

Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.39 by 23.08 percent. This is a 23.08 percent increase over earnings of $0.39 per share from the same

Benzinga Newsdesk